2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: Radioligand Therapy for Gastroenteropancreatic Neuroendocrine Tumors
2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: ctDNA as a Predictive Biomarker for Patients With Colon Cancer
Genitourinary Cancers MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial
Genitourinary Cancers Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer
Lung Cancer Closing the diagnostic gap: A three-step AI safety-net workflow to capture missed lung nodules on chest radiographs in routine clinical practice
